Privia Health Group, Inc. (NASDAQ:PRVA) CEO Sells $2,500,127.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Privia Health Group Stock Up 3.2 %

NASDAQ:PRVA traded up $0.58 during midday trading on Thursday, hitting $18.84. The company had a trading volume of 1,241,269 shares, compared to its average volume of 878,641. The company has a market capitalization of $2.25 billion, a PE ratio of 121.73, a P/E/G ratio of 4.36 and a beta of 0.78. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $25.92. The stock’s fifty day moving average price is $19.32 and its 200-day moving average price is $18.81.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The firm had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. Privia Health Group’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.06 earnings per share. As a group, research analysts forecast that Privia Health Group, Inc. will post 0.16 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Robert W. Baird increased their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Royal Bank of Canada reissued an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Barclays reduced their target price on Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating for the company in a report on Monday, May 20th. Evercore ISI lowered their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Finally, Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $24.86.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of PRVA. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group in the 2nd quarter worth approximately $26,000. Nisa Investment Advisors LLC raised its position in Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after purchasing an additional 930 shares during the period. Signaturefd LLC lifted its stake in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares during the last quarter. Park Place Capital Corp boosted its position in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after buying an additional 1,335 shares during the period. Finally, Covestor Ltd grew its stake in shares of Privia Health Group by 25.5% during the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock valued at $104,000 after buying an additional 1,076 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.